Addenbrooke's Hospital - Dept of Oncology

Cambridge

0 studies enrolling now · 2 studies all time

What they study most

Metastatic or Locally Advanced Unresectable Solid Tumors, Ovarian Cancer

Studies at this site

• Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) — Running, not enrolling
• Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301) — Running, not enrolling